Compounders Research Compare

Aclarion, Inc.(ACON)

Medical - Healthcare Information Services · Broomfield, CA

$2.31-0.03 (-1.28%)

Delayed quote: Oct 6, 2026, 2:05 PM EDT

About Aclarion, Inc.

Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.

Broomfield, CA

11 employees

www.aclarion.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Brent Ness

View full financials

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T18:05:33.210Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:05:33.210Z.

Quote observation: 2026-10-06T18:05:02.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 6,658,277
TTM free cash flow · period ending 2026-06-30: -8,184,835

FMP input reference: 1aa4897ea94b4447735fa2b7e4a8bb5a18d1bcefabda34b81af7232f4abbcb6a

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ACON Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

ACON Competitors' Price/FCF Ratio

Aclarion, Inc.

Current

Market Cap

$6.66M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Ensysce Biosciences, Inc.

Market Cap

$6.61M

Price/FCF Ratio

N/A

TTM Avg

1251.36

3Y Avg

3596.79

5Y Avg

3596.79

Enveric Biosciences, Inc.

Market Cap

$6.53M

Price/FCF Ratio

N/A

TTM Avg

2104.37

3Y Avg

2470.51

5Y Avg

5857.68

Curanex Pharmaceuticals Inc Common Stock

Market Cap

$6.90M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Bolt Biotherapeutics, Inc.

Market Cap

$6.94M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Co-Diagnostics, Inc.

Market Cap

$7.03M

Price/FCF Ratio

N/A

TTM Avg

6.05

3Y Avg

13.36

5Y Avg

13.36

KALA BIO, Inc.

Market Cap

$7.07M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Exicure, Inc.

Market Cap

$7.08M

Price/FCF Ratio

N/A

TTM Avg

2936.20

3Y Avg

2936.20

5Y Avg

2936.20

NeuroSense Therapeutics Ltd.

Market Cap

$6.95M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Biomerica, Inc.

Market Cap

$6.32M

Price/FCF Ratio

N/A

TTM Avg

129.84

3Y Avg

129.84

5Y Avg

129.84

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Aclarion, Inc. (ACON)	$6.66M	N/A	N/A	N/A	N/A
Ensysce Biosciences, Inc. (ENSC)vs ›	$6.61M	N/A	1251.36	3596.79	3596.79
Enveric Biosciences, Inc. (ENVB)vs ›	$6.53M	N/A	2104.37	2470.51	5857.68
Curanex Pharmaceuticals Inc Common Stock (CURX)vs ›	$6.90M	N/A	N/A	N/A	N/A
Bolt Biotherapeutics, Inc. (BOLT)vs ›	$6.94M	N/A	N/A	N/A	N/A
Co-Diagnostics, Inc. (CODX)vs ›	$7.03M	N/A	6.05	13.36	13.36
KALA BIO, Inc. (KALA)vs ›	$7.07M	N/A	N/A	N/A	N/A
Exicure, Inc. (XCUR)vs ›	$7.08M	N/A	2936.20	2936.20	2936.20
NeuroSense Therapeutics Ltd. (NRSN)vs ›	$6.95M	N/A	N/A	N/A	N/A
Biomerica, Inc. (BMRA)vs ›	$6.32M	N/A	129.84	129.84	129.84

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Growth Operating Margin All Metrics